介入治疗肾血管平滑肌脂肪瘤进展  

Advancements of interventional therapy for renal angiomyolipoma

作　　者：吕天石[1] 曹守金 王健[1] 邹英华[1] LYU Tianshi;CAO Shoujin;WANG Jian;ZOU Yinghua(Department of Interventional and Vascular Surgery, Peking University First Hospital, Beijing 100034, China)

机构地区：[1]北京大学第一医院介入血管外科,北京100034

出　　处：《中国介入影像与治疗学》2020年第12期755-758,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：肾脏血管平滑肌脂肪瘤(RAML)是常见的肾脏良性肿瘤,其发病隐匿,发生率较低;主要并发症包括腰痛和肾积水等,严重并发症为肿瘤破裂,出血凶险,预后不良。介入方法,包括动脉栓塞术、经皮消融术等现已成为治疗RAML的重要手段。本文对介入治疗RAML的研究进展进行综述。Renal angiomyolipoma(RAML)is a common renal benign tumor with low incidence,which is insidious.The complications of RAML mainly includes waist pain or hydronephrosis,and RAML rupture and bleeding is a serious complication with poor prognosis.Interventional therapies,including arterial embolization and percutaneous ablation,have become important means for treatment of RAML.The advancements of interventional treatment of RAML were reviewed in this article.

关 键 词：肾 血管肌脂瘤 介入治疗 

分 类 号：R692[医药卫生—泌尿科学] R815[医药卫生—外科学]